Institute of Molecular Biology

What Institute of Molecular Biology does

The Institute of Molecular Biology (IMB) is a private non-profit research institute (Institut für Molekulare Biologie gGmbH) established in 2009 and headquartered at Ackermannweg 4 in Mainz, Germany. It is funded primarily by the Boehringer Ingelheim Foundation and operates as a modern research centre focused on the molecular biology of the nucleus, with research organised around six overlapping themes: genome stability and DNA repair, epigenetics and nuclear dynamics, ageing/developmental biology and disease, RNA biology, computational biology and bioinformatics, and proteostasis and phase separation. The institute runs 26 active research groups under principal investigators including René Ketting, Christof Niehrs, Helle Ulrich, and Roland Euler (Commercial Managing Director), and provides seven state-of-the-art core facilities (Bioinformatics, Flow Cytometry, Genomics, Microscopy & Histology, Proteomics, Protein Production, Media Lab) plus three specialised competence hubs (AI in Biomedical Research, Single-Cell Genomics, Spatial Transcriptomics).

IMB's outputs are scientific rather than commercial: research is disseminated via peer-reviewed publications, international conferences, and collaborative networks, and the institute also operates a substantial training platform — the International PhD Programme (IPP), IMB Postdoc Programme (IPPro), NextGen Training Programme, International Summer School, and Advanced Training & Career Programme. The business model is non-commercial: IMB does not sell products or services on a revenue basis, relying on foundation and public grant funding, with external access to core facilities available on a collaborative basis. Strategic positioning is reinforced by participation in four DFG-funded Collaborative Research Centres (CRC 1361 on DNA repair, CRC 1551 bridging polymer and life sciences, CRC 1066 on nanoparticle-mediated tumour immunotherapy, CRC TRR156 on the skin immune system) and by multi-institutional partnerships including the Centre for Healthy Ageing and the CoAGE joint PhD programme with five additional German research centres.

Recent strategic emphasis is visible in the launch of an AI Competence Hub, the application of AlphaFold-based in silico prediction combined with cryo-electron microscopy for structural biology, and the development of translational immunotherapy and ageing research platforms alongside the basic science core. The institute maintains close collaborative ties with Johannes Gutenberg University Mainz and its University Medical Center, the Max Planck Institute for Polymer Research, the Leibniz Institute for Resilience Research, and TRON, and has been recognised externally via an ERC Advanced Grant (Edward Lemke) and a Biochemical Society Early Career Research Award (Laura Lorenzo-Orts).

Name

Institute of Molecular Biology

Legal name

Institut für Molekulare Biologie gGmbH

Website

https://imb.de

Company type

Private

Founded year

2009

Operating status

Operating

Short description

The Institute of Molecular Biology (IMB) is a Mainz-based non-profit research institute funded by the Boehringer Ingelheim Foundation that operates 26 research groups covering genome stability, epigenetics, RNA biology, and ageing, supported by seven core facilities, three AI/single-cell/spatial competence hubs, and a portfolio of PhD, postdoc, and training programmes for the international molecular biology community.

Ownership category

akta.pro rank

Product category

Molecular Biology Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Proteomics & Biomarker Analytical Testing (HLAGADAG), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

Keywords

• Molecular biology research
• Epigenetics research
• Genome stability
• Proteomics services
• Bioinformatics services

Headquarters

HQ city

Mainz

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Others

Distribution channels3 records

Marketing channels8 records

Core offering

The Institute of Molecular Biology is a non-profit research institute that conducts fundamental molecular biology research across 26 active research groups covering gene regulation, epigenetics, genome stability, DNA repair, RNA biology, ageing, computational biology, bioinformatics, proteostasis, and phase separation. It delivers its research through state-of-the-art core facilities, three specialised competence hubs (AI in biomedical research, single-cell genomics, spatial transcriptomics), and a structured portfolio of doctoral, postdoctoral, and advanced training programmes, while publishing findings in peer-reviewed journals and disseminating them via international conferences.

Product overview

The Institute of Molecular Biology (IMB) is a modern research centre focused on the molecular biology of the nucleus with overarching themes in gene regulation, epigenetics, and genome stability. IMB operates as a platform of research services and training programmes, including core facilities providing state-of-the-art technologies (Bioinformatics, Flow Cytometry, Genomics, Microscopy & Histology, Proteomics, Protein Production, Media Lab), multiple competence hubs (AI in Biomedical Research, Single-Cell Genomics, Spatial Transcriptomics), and comprehensive training programmes (International PhD Programme, IMB Postdoc Programme, NextGen Training Programme, International Summer School, Advanced Training & Career Programme). The institute also develops internal tools such as Scicle scientific management software and maintains specialized laboratory equipment in its E-Lab facility. IMB's research is organized into focus areas including Genome Stability & DNA Repair, Epigenetics & Nuclear Dynamics, Ageing Developmental Biology & Disease, RNA Biology, Computational Biology & Bioinformatics, and Proteostasis & Phase Separation.

Differentiator

Problem solved

Functional benefit

Products and services

• Core Facilities A bundled set of seven state-of-the-art technological service facilities covering Bioinformatics, Flow Cytometry, Genomics, Microscopy & Histology, Proteomics, Protein Production, and Media Lab; provides specialised research infrastructure to support molecular biology investigations for internal and external academic researchers.
• International PhD Programme (IPP) Flagship structured PhD training programme on epigenetics, genome stability, and ageing, conducted in partnership with Mainz University and its Medical Center; targets doctoral candidates seeking advanced research training in molecular biology.
• IMB Postdoc Programme (IPPro) Comprehensive postdoctoral training programme offering scientific and technical training, professional skills development, and career mentoring for researchers in molecular biology.
• NextGen Training Programme Training programme for junior researchers offered in collaboration with 14 participating research groups covering advanced molecular biology topics.
• International Summer School Annual intensive research programme providing international students exposure to molecular biology projects with researchers from around the world.
• Advanced Training & Career Programme Continuing education programme offering scientific and methodological training, professional skills development, career development, and scientific networking opportunities for researchers.
• Competence Hub for AI Utilisation in Biomedical Research Specialized competence hub providing AI and computational tools and expertise for biomedical research applications.
• Competence Hub Single-Cell Genomics Specialized competence hub offering expertise and services in single-cell genomic analysis and technologies for IMB researchers and external collaborators.
• Competence Hub Spatial Transcriptomics Specialized competence hub providing spatial transcriptomics analysis capabilities and expertise for biomedical research applications.

Quantifiable outcome

• Edward Lemke awarded ERC Advanced Grant for developing techniques to visualise proteins at nanometer-level resolution inside living cells in real-time
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature13 records

Partnerships

19 partnerships are on record, tiered core, flagship and minor.

• Johannes Gutenberg University Mainz (JGU)coreStrategic or Co-development PartnerClose collaborative partner hosting multiple joint research initiatives, the International PhD Programme, and various collaborative research centres including Centre for Healthy Ageing, ReALity, CRC 1361, CRC 1551, 4R, and GenEvo.
• University Medical Center MainzcoreStrategic or Co-development PartnerCollaborative partner in clinical and translational research, joint PhD programmes (IPP), and research initiatives including Centre for Healthy Ageing, SHARP, CoAGE, and multiple collaborative research centres.
• Centre for Healthy AgeingflagshipStrategic or Co-development PartnerA centre for basic and clinical research on ageing and age-related disease, jointly established with Mainz University, its Medical Center, the Leibniz Institute for Resilience Research, and TRON.
• CRC 1361 (SFB 1361)flagshipStrategic or Co-development PartnerThe largest network on DNA repair and genome stability in Germany, involving groups in Mainz, Darmstadt, Frankfurt, and Munich. IMB serves as a key participant in this collaborative research centre.
• CRC 1551flagshipStrategic or Co-development PartnerAn initiative bridging polymer and life sciences to understand biological processes such as ageing, in collaboration with Mainz University, its Medical Center, and the Max Planck Institute for Polymer Research.
• Max Planck Institute for Polymer ResearchcoreStrategic or Co-development PartnerCollaborates with IMB on CRC 1551 focusing on polymer science applications in biological research, particularly in understanding ageing processes.
• Leibniz Institute for Resilience ResearchcoreStrategic or Co-development PartnerPartner in the Centre for Healthy Ageing initiative focusing on resilience research and its applications to healthy ageing.
• TRON (Translational Oncology)coreStrategic or Co-development PartnerCollaborative partner in the Centre for Healthy Ageing, bringing expertise in translational oncology and immunotherapy research.
• Helmholtz MunichcoreStrategic or Co-development PartnerCollaborative partner in the CoAGE joint PhD programme focused on understanding why diseases are more common in old age and how to age healthily.
• German Center for Neurodegenerative Diseases (DZNE)coreStrategic or Co-development PartnerPartner in CoAGE programme addressing neurodegenerative diseases and healthy ageing research.
• University Medical Center Hamburg-EppendorfcoreStrategic or Co-development PartnerCollaborative partner in the CoAGE joint PhD programme focused on age-related diseases and healthy ageing.
• Leipzig UniversitycoreStrategic or Co-development PartnerPartner in CoAGE programme addressing age-related diseases and healthy ageing research.
• Greifswald University HospitalcoreStrategic or Co-development PartnerCollaborative partner in the CoAGE joint PhD programme focused on healthy ageing research.
• CRC 1066 (SFB 1066)flagshipStrategic or Co-development PartnerDFG-funded collaborative research centre on 'Nanoparticle-mediated tumour immunotherapy'. IMB's Grabbe Lab serves as the Speaker of this centre, collaborating with the Department of Chemistry and Max Planck Institute for Polymer Research in Mainz, as well as researchers in Würzburg and Leiden.
• CRC TRR156flagshipStrategic or Co-development PartnerDFG-funded collaborative research centre on the 'Skin immune system'. IMB's Grabbe Lab serves as the Site Coordinator for Mainz, collaborating with labs in Heidelberg and Tübingen.
• JGU Research Center for Immunotherapy (FZI)coreStrategic or Co-development PartnerIMB's Grabbe Lab participates in the JGU Research Center for Immunotherapy, advancing immunotherapy research together with Prof. Dr Tobias Bopp.
• Lorenzo-Orts LabminorStrategic or Co-development PartnerCollaborative research partnership between Hohmann Lab and Lorenzo-Orts Lab focusing on gene expression biology research.
• Department of Chemistry (Mainz)coreStrategic or Co-development PartnerAcademic collaboration within CRC 1066 on nanoparticle-based immunotherapy research.
• Leiden University (Netherlands)minorStrategic or Co-development PartnerInternational collaboration partner in CRC 1066 nanoparticle research.

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• European Molecular Biology Laboratory (EMBL): Intergovernmental life-sciences research organisation with sites across Europe offering core facilities, training, and services in molecular biology. Comparable to IMB as a research and training platform but at substantially larger scale, broader thematic scope, and more diversified international funding.
• Helmholtz Centre Munich (Helmholtz Munich): Large German research centre with significant programmes in metabolic health, ageing, and environmental health. Directly comparable to IMB on the CoAGE joint PhD programme and shares ageing/disease research themes, though operating at a much larger scale and broader thematic scope.

Regional players

• New York Genome Center: New York-based genomics-focused research organisation with core facility services in sequencing, single-cell, and spatial omics. Comparable on the core-facility and genomics-services side, but U.S.-focused and with a more translational/commercial orientation than IMB.

Direct peers

• MRC Laboratory of Molecular Biology (LMB): Cambridge-based MRC research institute with a long history of breakthrough discoveries in molecular biology, structural biology, and cell biology. Closely comparable research scope (gene regulation, RNA biology, structural biology) and institute-style research model.
• Cold Spring Harbor Laboratory: New York-based independent research and education institution with strong programmes in genetics, genomics, cancer biology, and neuroscience. Comparable as an independent research/training institute with a similar model of small research groups plus core facilities.
• Francis Crick Institute: London-based biomedical discovery institute with ~100 research groups covering molecular biology, genetics, and cancer biology. Highly comparable as a non-university research institute with a similar group-based model, training programmes, and core facilities, but operating at a larger scale.
• Max Planck Institute for Molecular Genetics: Berlin-based Max Planck institute focused on molecular genetics, genome regulation, and DNA repair. Closely comparable to IMB in mission, scale of research groups, and academic research model, and a recurring collaborator/competitor for DFG CRC funding in Mainz-adjacent areas.
• Centre for Genomic Regulation (CRG): Barcelona-based institute with research groups in genomics, gene regulation, bioinformatics, and cell biology. Comparable European research-institute peer with similar core-facility and training infrastructure and a comparable focus on molecular biology of the nucleus.
• Whitehead Institute for Biomedical Research: MIT-affiliated independent biomedical research institute with focused research groups in molecular biology, genetics, and disease biology. Comparable in scale, group structure, and the basic-research-with-translational-aspiration model.
• Friedrich Miescher Institute for Biomedical Research (FMI): Basel-based independent biomedical research institute affiliated with the Novartis Research Foundation, focused on epigenetics, neurobiology, and quantitative biology. Highly comparable in scale, group structure, and foundation-funded independent research model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/imbmainz
• Facebookfacebook.com/imbmainz
• LinkedInlinkedin.com/company/institute-of-molecular-biology-imb-
• Xx.com/imbmainz

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute of Molecular Biology